Adaptive Biotechnologies Corp vs Applied Digital Corporation — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Applied Digital Corporation trades at $31.43 (market cap $8.55B). The key difference: Applied Digital Corporation is far larger — about 2.1× Adaptive Biotechnologies Corp's market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, Applied Digital Corporation nearer its low. Which is the better fit depends on your goals.
| ADPT | APLD | |
|---|---|---|
Market Cap | $4.04B | $8.55B |
Sector | Health | Technology |
52-Week High | $25.45 | $49.65 |
52-Week Low | $12.30 | $13.89 |
Enterprise Value | $4.10B | $12.06B |
Trailing returns across standard periods
Latest headlines on both assets
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →Applied Digital provides high-performance computing (HPC) infrastructure and cloud services. It designs and operates data centers tailored for AI, machine learning, and other intensive digital workloads across North America.
Read more on APLD →